https://www.selleckchem.com/Wnt.html
Metaplastic breast cancer (MBC) is a rare tumor with aggressive biological behavior. This study aimed to evaluate the efficacy of post-mastectomy radiotherapy (PMRT) on patients with low-risk (T1N0M, intermediate-risk (T1-2N1M0 and T3N0M, and high-risk (T1-4N2-3M0 and T4N0-1M MBC propensity-score matching (PSM). We analyzed information from the Surveillance, Epidemiology, and End Results (SEER) public-use database from 1975 to 2016 for MBC incidence trends and compared overall survival (OS) and breast cancer-specific survival (BCSS) between gr
Like
Comment
Share
